The Cole Memo

The federal cannabis rescheduling hearings are underway, and this episode breaks down the biggest developments from the first two days. We cover testimony from DEA and FDA officials, arguments over the government's shift from a five-part to a two-part medical use test, and reactions from opponents of the proposed move to Schedule III. We also discuss what the hearings do and do not address, including why the proceedings focus on regulation rather than legalization. Plus, we look at the U.S. Supreme Court's recent gun rights ruling for cannabis consumers and how that decision is already influencing other cases, including potential implications for Illinois. As always, you'll find links to the original reporting and sources discussed throughout the episode. Watch video version and read full show notes here: https://thecolememo.com/2026/06/30/e296/